Clinical Trial Update: High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers high-dose donor hematopoietic stem cell infusion being evaluated for relapsed or refractory acute myeloid leukemia in Phase 1/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Conditions: Leukemia, Myeloid | Phase 1, Phase 2 | Status: UNKNOWN